Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
miRagen Therapeutics to Report First Quarter 2019 Financial Results and Host a Conference Call on May 8th | ||
By: Nasdaq / GlobeNewswire - 25 Apr 2019 | Back to overview list |
|
BOULDER, Colo., April 25, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a conference call on Wednesday, May 8th, at 4:30 p.m. ET to discuss its financial results for the first quarter ended March 31, 2019. Participants may access the call by dialing 877-407-0789 in the U.S. or 201-689-8562 outside the U.S. and providing the conference ID number: 13689475. The call will also be webcast and can be accessed from the Investors and Media section of the Company’s website at www.miragen.com. A replay of this conference call will be available on miRagen’s website approximately one hour after the event. About miRagen Therapeutics, Inc. For information on clinical trials please visit www.clinicaltrials.gov. Investor/Media Contact: |
||
|
||
Copyright 2019 Nasdaq / GlobeNewswire | Back to overview list |